Overview

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

Status:
RECRUITING

Trial end date:
2030-10-31

Target enrollment:

Participant gender:

Summary

To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.

Phase:

PHASE2

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Treatments:

Calcium Dobesilate
Dexamethasone
Diphenhydramine
Famotidine
Paclitaxel